C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98%
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

Wall Street
Price Targets

T5O Price Targets Summary
CytoTools AG

Wall Street analysts forecast T5O stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for T5O is 25.93 EUR with a low forecast of 25.68 EUR and a high forecast of 26.7 EUR.

Lowest
Price Target
25.68 EUR
75% Downside
Average
Price Target
25.93 EUR
74% Downside
Highest
Price Target
26.7 EUR
74% Downside
CytoTools AG Competitors:
Price Targets
HALO
Halozyme Therapeutics Inc
20% Upside
AMGN
Amgen Inc
4% Upside
VIR
Vir Biotechnology Inc
347% Upside
688235
Beigene Ltd
7% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Downside
ZEAL
Zealand Pharma A/S
32% Upside
ABBV
Abbvie Inc
7% Upside
INIT
Initiator Pharma A/S
240% Upside

Revenue
Forecast

Revenue Estimate
CytoTools AG

For the last 9 years the compound annual growth rate for CytoTools AG's revenue is -14%. The projected CAGR for the next 1 year is 24%.

-14%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-91%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CytoTools AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss

Net Income
Forecast

Net Income Estimate
CytoTools AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is T5O's stock price target?
Price Target
25.93 EUR

According to Wall Street analysts, the average 1-year price target for T5O is 25.93 EUR with a low forecast of 25.68 EUR and a high forecast of 26.7 EUR.

What is CytoTools AG's Revenue forecast?
Projected CAGR
24%

For the last 9 years the compound annual growth rate for CytoTools AG's revenue is -14%. The projected CAGR for the next 1 year is 24%.

Back to Top